Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3588]

HDAC6 can control tumour growth and halt metastasis in triple-negative breast cancer

HDAC6 can control tumour growth and halt metastasis in triple-negative breast cancer

How tumour cells evade the immune defence

How tumour cells evade the immune defence

A blood test could predict who benefits from immunotherapy

A blood test could predict who benefits from immunotherapy

FDA grants accelerated approval to tafasitamab-cxix for diffuse large B-cell lymphoma

FDA grants accelerated approval to tafasitamab-cxix for diffuse large B-cell lymphoma

$FDA approves brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma$

FDA approves brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma

FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma

FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma

Immune cell steroids help tumours suppress the immune system, offering new drug targets

Immune cell steroids help tumours suppress the immune system, offering new drug targets

NICE recommends avelumab with axitinib for first-line treatment of adult patients with advanced renal cell carcinoma (ARCC)

NICE recommends avelumab with axitinib for first-line treatment of adult patients with advanced renal cell...

Precision medicine identifies key recurring mutation in head and neck cancers

Precision medicine identifies key recurring mutation in head and neck cancers

Investigational breast cancer vaccine plus immune therapy work well in tandem

Investigational breast cancer vaccine plus immune therapy work well in tandem

More from ecancer